The prevalence of diabetes mellitus is increasing at an epidemic level, leading to a
consequent increase of its chronic complications, including neuropathy. Diabetic neuropathy …

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare,
heterogeneous, but treatable autoimmune-mediated peripheral neuropathy characterized by …

Background Immune-mediated neuropathies, such as chronic inflammatory demyelinating
polyneuropathy (CIDP) are treatable neuropathies. Among individuals with diabetic …

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare but disabling
disorder that often requires long‐term immunomodulatory treatment. Background incidence …

Background and aims Although dysautonomia is a well-recognized complication of acute
demyelinating polyradiculoneuropathy, it is rarely reported and evaluated in chronic …

Diabetic polyneuropathy (DPN) shares overlap** clinical and electrodiagnostic features
with chronic inflammatory demyelinating polyneuropathy (CIDP), which complicates the …

Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare
disease, but it is one of the most common inflammatory neuropathies in the population. It is …

Objective The current research aimed to analyze the alterations within the motor cortex and
pyramidal pathways and their association with the degree of damage within the peripheral …

This review describes the most common PN syndromes associated with monoclonal
gammopathy, such as anti-myelin-associated glycoprotein neuropathy, light chain …

Although the validity of the 2021 EFNS/PNS diagnostic criteria for atypical CIDP is unknown,
they will hopefully lead to greater uniformity in the selection of patients to be enrolled in …